These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18197761)

  • 1. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.
    Proctor RA
    Clin Infect Dis; 2008 Feb; 46(4):584-93. PubMed ID: 18197761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
    Al-Shawwa BA; Wegner D
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus: a community concern.
    Hedge DD
    S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment: Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Hmouda H; Jemni L
    Ann Pharmacother; 2004 Nov; 38(11):1970-1; author reply 1971-2. PubMed ID: 15466908
    [No Abstract]   [Full Text] [Related]  

  • 7. [Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)--a new challenge in the ambulatory setting?].
    Buehlmann M; Chuard C
    Rev Med Suisse; 2007 Oct; 3(128):2289-90, 2292-3. PubMed ID: 17985605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
    Phillips S; MacDougall C; Holdford DA
    Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M; Lawrence KR
    Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hyun DY; Mason EO; Forbes A; Kaplan SL
    Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic options for treating community-acquired MRSA.
    Powell JP; Wenzel RP
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control.
    Wenzel RP; Bearman G; Edmond MB
    Int J Antimicrob Agents; 2007 Sep; 30(3):210-2. PubMed ID: 17566712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum iliopsoas pyomyositis due to community-acquired methicillin-resistant Staphylococcus aureus.
    Sokolov KM; Kreye E; Miller LG; Choi C; Tang AW
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):535-8. PubMed ID: 17666656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
    Roesch A; Linde HJ; Landthaler M; Vogt T
    Arch Dermatol; 2005 Dec; 141(12):1520-2. PubMed ID: 16365252
    [No Abstract]   [Full Text] [Related]  

  • 17. [Community-acquired methicillin-resistant Staphylococcus aureus disseminated disease].
    Brezzo C; Cecchini D; Biscione F; Orduna T; Costa N; Quinteros M
    Medicina (B Aires); 2006; 66(5):443-6. PubMed ID: 17137175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.